MICROBIOTIX, INC
Translational studies to advance Filociclovir to IND submission for the treatment of adenoviral conjunctivitis and acute keratoconjunctivitis
Translational studies to advance Filociclovir to IND submission for the treatment of adenoviral conjunctivitis and acute keratoconjunctivitis is a funding opportunity from MICROBIOTIX, INC, up to 669859, closing January 31, 2028.
Jan 31, 2028
(549d left)Overview
Project Summary/Abstract The long-term goal of this project, to develop filociclovir (FCV) for the safe and effective treatment of human adenovirus (HAdV) ocular infections, especially HAdV-related epidemic keratoconjunctivitis (EKC), a stated National Eye Institute (NEI) research priority. There are currently no…